Routine

Focal epilepsy (localisation-related) management

Focal-onset seizures · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Focal-onset epilepsy arising from a discrete cortical region, commonly temporal lobe, presenting with focal aware, focal impaired-awareness or focal-to-bilateral tonic-clonic seizures. Requires structural imaging and tailored sodium-channel or broad-spectrum medication.

Red flags

  • Progressive focal deficit or new lesion on imaging
  • Drug-resistant seizures despite two appropriate agents
  • Frequent focal-to-bilateral tonic-clonic seizures
  • Suicidal ideation on antiseizure medication
  • Status epilepticus

Assessment

Differential diagnosis

  • Genetic generalised epilepsy
  • Psychogenic non-epileptic seizures
  • Syncope with convulsive movements
  • Transient ischaemic attack
  • Panic attacks or dissociative episodes
  • Hypoglycaemia or metabolic events

Investigations

  • MRI brain with epilepsy protocol (hippocampal views) to seek structural lesion
  • Interictal EEG for focal epileptiform discharges
  • Prolonged or sleep-deprived EEG if diagnosis uncertain
  • ECG to exclude cardiac syncope
  • Bloods including glucose, electrolytes, calcium
  • Video-EEG telemetry if diagnosis or localisation unclear

Management

  • Confirm focal semiology (automatisms, deja vu, rising epigastric sensation, focal motor signs)
  • Image with MRI to identify mesial temporal sclerosis, cortical dysplasia or tumour
  • Classify seizure type and estimate recurrence risk before starting therapy
  • Offer first-line monotherapy with lamotrigine or levetiracetam per current guidance
  • Titrate slowly to lowest effective dose and reassess seizure diary
  • Add or switch to alternative agent if first drug fails at adequate dose
  • Screen for and manage mood disorder and medication adverse effects
  • Give driving, safety, alcohol and sleep advice
  • Identify drug-resistant epilepsy early (failure of two tolerated appropriate drugs)
  • Refer drug-resistant cases for epilepsy surgery evaluation

Drugs & doses

Lamotrigine 25 mg PO daily, titrate over weeks to 100-200 mg BD
Levetiracetam 250-500 mg PO BD, titrate to 1000-1500 mg BD
Lacosamide 50 mg PO BD, titrate to 100-200 mg BD
Carbamazepine 100-200 mg PO BD, titrate to 400-600 mg BD
Zonisamide 50 mg PO daily, titrate to 100-300 mg daily
Brivaracetam 25-50 mg PO BD as alternative

Disposition

Outpatient epilepsy clinic. Refer drug-resistant focal epilepsy to a tertiary epilepsy surgery centre for video-EEG and presurgical evaluation.

Complications & pitfalls

  • Drug resistance in up to a third of patients
  • Memory and mood impairment (temporal lobe involvement)
  • Injury from focal-to-bilateral tonic-clonic seizures
  • SUDEP
  • Medication interactions and adverse effects

Exam pearls

  • Identify drug-resistant epilepsy early and refer for surgical workup rather than cycling endless drugs
  • Mesial temporal sclerosis is a surgically remediable cause
  • Enzyme-inducing drugs (carbamazepine) reduce efficacy of hormonal contraception and many drugs
  • Screen for depression which is common and under-treated

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.